Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Pelacarsen Cuts Lipoprotein Apheresis Need in CVD
Added: 1 month ago Source:  Radcliffe CVRM
For patients with elevated lipoprotein(a) [Lp(a)] and established cardiovascular disease (CVD), weekly lipoprotein apheresis (LA) is the only approved treatment, but it represents a significant burden. The Lp(a)FRONTIERS APHERESIS trial investigated whether the investigational therapy pelacarsen could reduce the need for this invasive procedure.¹Mechanism of ActionPelacarsen is a hepatocyte… View more

Cardiovascular Kidney Metabolic
Lilia Sierra-Galan
Job title: Head of Cardiology
Personal History Dr Lilia M. Sierra-Galan is based in Mexico City, Mexico, where she works as the head of cardiology at the Santa Fe Campus of the American British Cowdray Medical Center. Academic History Dr Lilia M. Sierra-Galan, MD earned her MD in Mexico and her cardiovascular imaging fellowship at the National Institute of Health in Bethesda, Washington DC and InCor in Sao Paulo,… View more
Ajay Kirtane
Job title: Professor of Clinical Medicine
Ajay J Kirtane, is Professor of Medicine at the Columbia University Medical Center (CUMC) and Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian (NYP) Hospital / CUMC. Dr. Kirtane is an internationally-renowned leader in Interventional Cardiology, specializing in the care of patients with complex coronary and peripheral vascular disease. In addition to his… View more
Added: 12 months ago Source:  Radcliffe CVRM
AUTHOR: Ola WisniewskaSodium-glucose cotransporter-2 (SGLT2) inhibitors significantly slow kidney function decline in patients with type 2 diabetes, with even greater benefits seen in those with higher body mass index (BMI), according to a nationwide Japanese study published recently.1Researchers analyzed data from 2,165 patients prescribed SGLT2 inhibitors compared with 4,330 matched patients on… View more

Prevention & Chronic Conditions
Added: 1 year ago
Explore the cardiovascular breakthroughs shaping AHA 2024!Join renowned experts Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) as they preview the most impactful late-breaking studies poised to make waves at this year’s AHA Conference. Dive into their expert analysis and gain key insights into the studies that are set to drive the future of cardiovascular… View more

Intervention

Cardiovascular Kidney Metabolic
Aaron Isaacs
Personal History Dr Aaron Isaacs is based in the Netherlands, where he works in the Department of Physiology, Cardiovascular Research Institute Maastricht at Maastricht University. Academic History Dr Aaron Isaacs completed his baccalaureate degree at the University of California, Berkeley in 1994. In 2002, he moved to the Netherlands, where he embarked on his PhD studies in genetic… View more
Michael D Shapiro
Job title: Director of the Center for Preventive Cardiology
Personal History Dr Shapiro lives in Winston-Salem with his wife and their two children. In his spare time, he enjoys travelling and hiking. Academic History Dr Shapiro completed medical school in 1998 at the UMDNJ School of Osteopathic Medicine. After completing a cardiology fellowship at the Beth Israel Medical Center, he spent two additional years in a clinical and research… View more
Job title: Adjunct Professor of Pharmacology
John McNeill
Job title: Professor and head of School of Public Health and Preventive Medicine
After graduating in medicine from the University of Adelaide Professor McNeil undertook specialist training to become qualified as a consultant in internal medicine and clinical pharmacology. He completed a PhD in Clinical Pharmacology at Melbourne University and was awarded a National Heart Foundation overseas postgraduate research scholarship to study epidemiology at the London School of… View more
Susan Dent
Research Area(s) / Expertise:

Cardio-oncology

 Job title: President IC-OS and Co-Director Cardio-Oncology
Dr. Dent attended McMaster University Medical School in Hamilton, Ontario, Canada and completed her residency training in Internal Medicine and Medical Oncology at the Ottawa Hospital, University of Ottawa, Ontario, Canada. She subsequently completed a post graduate research fellowship in clinical trials at the Canadian Cancer Trials Group (CCTG) in Kingston, Ontario, and was appointed as a staff… View more